Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Co-administered Varicella, MMR, and DTaP Vaccines in Children
NCT06891872Phase 4Not yet recruiting
- Sponsor
- Sinovac Biotech Ltd.
- Start
- May 2025
- Primary completion
- Dec 2025
- Countries
- 1
01
Overview
A Phase 4 trial of varicella virus vaccine live in chickenpox, sponsored by Sinovac Biotech Ltd.. Planned start May 2025; status: not yet recruiting.
02
Drugs
varicella virus vaccine live
03
Conditions
chickenpox
Beyond the preview
Go deeper on NCT06891872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06891872.